Women’s health innovation is accelerating. From AI enabled diagnostics to personalised care pathways, FemTech is reshaping how products are built, tested and adopted. At the same time, regulation, data protection and investment scrutiny are growing, which raises new questions for founders, investors and corporates across the sector.
Over the coming weeks, we’ll release an eight part article series from our cross sector Life Sciences, Technology and Consumer Goods teams – leading up to our flagship London event on 12 May 2026, with a final article to follow after the event.
Available Articles
This opening article in DLA Piper’s FemTech series introduces the evolving legal landscape for women’s health innovation. It explores the regulatory, commercial and risk considerations shaping the sector, setting the foundation for deeper analysis of key legal issues facing FemTech companies and their partners.
26 March 2026
FemTech is booming - but with growth comes risk. As apps collect ever more intimate data, privacy, cybersecurity and regulation move centre stage. Explore why trust, transparency and robust governance are becoming critical battlegrounds for FemTech innovators navigating a fast evolving global landscape.
30 March 2026
Historically, women’s health has received less attention and funding in medical research and health related technological development. Explore how FemTech innovators can protect and commercialise intellectual property in a fast-growing women’s health sector.
10 April 2026
Collaborating with women’s health startups gives corporates and investors a chance to drive innovation with social and economic impact. For FemTech innovators, partnerships unlock funding, regulatory and clinical expertise, and distribution, accelerating scale and trust. This article explores collaboration models, risks and key success factors.
14 April 2026
AI is reshaping FemTech, bringing innovation and responsibility. As medical device rules, data protection and cybersecurity obligations tighten, companies must address bias, explainability, autonomy and equitable access.
21 April 2026
